MedPath

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Phase 2
Completed
Conditions
Endometrial Cancer
Interventions
Registration Number
NCT00003127
Lead Sponsor
SWOG Cancer Research Network
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with metastatic, recurrent, or refractory endometrial cancer.

Detailed Description

OBJECTIVES: I. Evaluate the efficacy of paclitaxel and carboplatin with amifostine on progression free survival and overall survival in patients with metastatic or recurrent epithelial endometrial carcinoma not amenable to surgery or radiotherapy. II. Evaluate response (confirmed and unconfirmed partial response and complete response) rate to this regimen in this patient population. III. Assess the nature and degree of toxicity of this regimen in these patients.

OUTLINE: Patients receive paclitaxel IV over 3 hours, then amifostine IV over 10 minutes, followed fifteen minutes later by carboplatin IV over 30-60 minutes on day 1. Courses repeat every 28 days. Treatment continues for 6 courses in the absence of disease progression. Patients are followed every 6 months for 2 years, then annually thereafter.

PROJECTED ACCRUAL: A total of 35 to 50 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
57
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
carbo, taxol, amifostineamifostine trihydratecarbo, taxol, amifostine
carbo, taxol, amifostinecarboplatincarbo, taxol, amifostine
carbo, taxol, amifostinepaclitaxelcarbo, taxol, amifostine
Primary Outcome Measures
NameTimeMethod
Progression free survival6 months

from date of registration to date of first observation of progressive disease, deathe due to any cause, or early discontinuation of treatment.

Secondary Outcome Measures
NameTimeMethod
overall survival6 months

From date of registration to date of death due to any cause

responseafter 12 and 24 weeks

Greater than or equal to 50% decrease under baseline in the sum of products of perpendicular diameters of all measurable lesions. No disease progression. No new lesions.

toxicityWeekly X 3, q 4 weeks X 6 cycles

assessment per SWOG toxicity criteria

Trial Locations

Locations (94)

Jonsson Comprehensive Cancer Center, UCLA

🇺🇸

Los Angeles, California, United States

CCOP - Atlanta Regional

🇺🇸

Atlanta, Georgia, United States

Providence Hospital - Southfield

🇺🇸

Southfield, Michigan, United States

CCOP - Columbus

🇺🇸

Columbus, Ohio, United States

CCOP - Dayton

🇺🇸

Kettering, Ohio, United States

Veterans Affairs Medical Center - Dallas

🇺🇸

Dallas, Texas, United States

University of Texas Medical Branch

🇺🇸

Galveston, Texas, United States

Cleveland Clinic Cancer Center

🇺🇸

Cleveland, Ohio, United States

Veterans Affairs Medical Center - Seattle

🇺🇸

Seattle, Washington, United States

CCOP - Southern Nevada Cancer Research Foundation

🇺🇸

Las Vegas, Nevada, United States

Barrett Cancer Center, The University Hospital

🇺🇸

Cincinnati, Ohio, United States

Veterans Affairs Medical Center - Cincinnati

🇺🇸

Cincinnati, Ohio, United States

University of Texas Health Science Center at San Antonio

🇺🇸

San Antonio, Texas, United States

Veterans Affairs Medical Center - San Antonio (Murphy)

🇺🇸

San Antonio, Texas, United States

Veterans Affairs Medical Center - Salt Lake City

🇺🇸

Salt Lake City, Utah, United States

USC/Norris Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

Beckman Research Institute, City of Hope

🇺🇸

Los Angeles, California, United States

MBCCOP - University of South Alabama

🇺🇸

Mobile, Alabama, United States

Huntsman Cancer Institute

🇺🇸

Salt Lake City, Utah, United States

MBCCOP - Massey Cancer Center

🇺🇸

Richmond, Virginia, United States

Swedish Cancer Institute

🇺🇸

Seattle, Washington, United States

CCOP - Virginia Mason Research Center

🇺🇸

Seattle, Washington, United States

CCOP - Greater Phoenix

🇺🇸

Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Hayden)

🇺🇸

Phoenix, Arizona, United States

University of California Davis Medical Center

🇺🇸

Sacramento, California, United States

UCSF Cancer Center and Cancer Research Institute

🇺🇸

San Francisco, California, United States

Veterans Affairs Medical Center - San Francisco

🇺🇸

San Francisco, California, United States

Barbara Ann Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

Veterans Affairs Medical Center - Denver

🇺🇸

Denver, Colorado, United States

University of Colorado Cancer Center

🇺🇸

Denver, Colorado, United States

Veterans Affairs Medical Center - Detroit

🇺🇸

Detroit, Michigan, United States

Veterans Affairs Medical Center - Ann Arbor

🇺🇸

Ann Arbor, Michigan, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

CCOP - Southeast Cancer Control Consortium

🇺🇸

Winston-Salem, North Carolina, United States

Oklahoma Medical Research Foundation

🇺🇸

Oklahoma City, Oklahoma, United States

Veterans Affairs Medical Center - Oklahoma City

🇺🇸

Oklahoma City, Oklahoma, United States

Oregon Cancer Center at Oregon Health Sciences University

🇺🇸

Portland, Oregon, United States

Veterans Affairs Medical Center - Portland

🇺🇸

Portland, Oregon, United States

CCOP - Columbia River Program

🇺🇸

Portland, Oregon, United States

CCOP - Northwest

🇺🇸

Tacoma, Washington, United States

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

Veterans Affairs Medical Center - Tucson

🇺🇸

Tucson, Arizona, United States

Veterans Affairs Medical Center - Little Rock (McClellan)

🇺🇸

Little Rock, Arkansas, United States

Veterans Affairs Medical Center - Long Beach

🇺🇸

Long Beach, California, United States

Veterans Affairs Outpatient Clinic - Martinez

🇺🇸

Martinez, California, United States

CCOP - Bay Area Tumor Institute

🇺🇸

Oakland, California, United States

CCOP - Santa Rosa Memorial Hospital

🇺🇸

Santa Rosa, California, United States

CCOP - Mount Sinai Medical Center

🇺🇸

Miami Beach, Florida, United States

CCOP - Christiana Care Health Services

🇺🇸

Wilmington, Delaware, United States

David Grant Medical Center

🇺🇸

Travis Air Force Base, California, United States

Cancer Research Center of Hawaii

🇺🇸

Honolulu, Hawaii, United States

Dwight David Eisenhower Army Medical Center

🇺🇸

Fort Gordon, Georgia, United States

Tripler Army Medical Center

🇺🇸

Honolulu, Hawaii, United States

Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital)

🇺🇸

Hines, Illinois, United States

CCOP - Central Illinois

🇺🇸

Decatur, Illinois, United States

Loyola University Medical Center

🇺🇸

Maywood, Illinois, United States

CCOP - Wichita

🇺🇸

Wichita, Kansas, United States

Veterans Affairs Medical Center - Wichita

🇺🇸

Wichita, Kansas, United States

Veterans Affairs Medical Center - Lexington

🇺🇸

Lexington, Kentucky, United States

Albert B. Chandler Medical Center, University of Kentucky

🇺🇸

Lexington, Kentucky, United States

MBCCOP - LSU Medical Center

🇺🇸

New Orleans, Louisiana, United States

Veterans Affairs Medical Center - New Orleans

🇺🇸

New Orleans, Louisiana, United States

Tulane University School of Medicine

🇺🇸

New Orleans, Louisiana, United States

Louisiana State University Health Sciences Center - Shreveport

🇺🇸

Shreveport, Louisiana, United States

Veterans Affairs Medical Center - Shreveport

🇺🇸

Shreveport, Louisiana, United States

Veterans Affairs Medical Center - Boston (Jamaica Plain)

🇺🇸

Jamaica Plain, Massachusetts, United States

University of Michigan Comprehensive Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

Veterans Affairs Medical Center - Kansas City

🇺🇸

Kansas City, Missouri, United States

CCOP - Grand Rapids Clinical Oncology Program

🇺🇸

Grand Rapids, Michigan, United States

Veterans Affairs Medical Center - Biloxi

🇺🇸

Biloxi, Mississippi, United States

Keesler Medical Center - Keesler AFB

🇺🇸

Keesler AFB, Mississippi, United States

CCOP - Kansas City

🇺🇸

Kansas City, Missouri, United States

Veterans Affairs Medical Center - Jackson

🇺🇸

Jackson, Mississippi, United States

CCOP - Cancer Research for the Ozarks

🇺🇸

Springfield, Missouri, United States

St. Louis University Health Sciences Center

🇺🇸

Saint Louis, Missouri, United States

CCOP - St. Louis-Cape Girardeau

🇺🇸

Saint Louis, Missouri, United States

MBCCOP - University of New Mexico HSC

🇺🇸

Albuquerque, New Mexico, United States

Veterans Affairs Medical Center - Albuquerque

🇺🇸

Albuquerque, New Mexico, United States

Veterans Affairs Medical Center - Brooklyn

🇺🇸

Brooklyn, New York, United States

CCOP - North Shore University Hospital

🇺🇸

Manhasset, New York, United States

Herbert Irving Comprehensive Cancer Center

🇺🇸

New York, New York, United States

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.

🇺🇸

Syracuse, New York, United States

Veterans Affairs Medical Center - Dayton

🇺🇸

Dayton, Ohio, United States

CCOP - Greenville

🇺🇸

Greenville, South Carolina, United States

CCOP - Upstate Carolina

🇺🇸

Spartanburg, South Carolina, United States

Brooke Army Medical Center

🇺🇸

Fort Sam Houston, Texas, United States

Texas Tech University Health Science Center

🇺🇸

Lubbock, Texas, United States

Veterans Affairs Medical Center - Temple

🇺🇸

Temple, Texas, United States

CCOP - Scott and White Hospital

🇺🇸

Temple, Texas, United States

Boston Medical Center

🇺🇸

Boston, Massachusetts, United States

CCOP - Montana Cancer Consortium

🇺🇸

Billings, Montana, United States

Arizona Cancer Center

🇺🇸

Tucson, Arizona, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath